FEATURED

Use of IL-12 as Anticancer Agent

Recent research has indicated the potential for IL-12 therapy to be effective in combination with new and emerging biologics including other immunomodulatory drugs.

Optimism, Prognostic Awareness Not Mutually Exclusive

A study explored patient and caregiver awareness of disease curability and life expectancy with malignant glioma.

Updated 2016 NCCN Guidelines for MM

Several new regimen options for the treatment of as well as the recently FDA-approved combination drug regimens are among the changes made.

Rising Incidence of AKI Following Nephrectomy

Acute kidney injury incidence after radical nephrectomy and partial nephrectomy is increasing.

Impact of Lifestyle on Colorectal Cancer

The link between lifestyle and colorectal cancer has been increasingly studied, highlighting the potential impact of the standard American diet and inactivity.

FDA Approves Second Biosimilar, Despite Concerns

Ongoing litigation over patent protection and concern about drug labeling guidance and potential safety issues have slowed the availability of biosimilars.

New NCCN Guidelines for Melanoma

A record number of new agents have been approved in the treatment of melanoma in the past 5 years.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

AIs Have Similar CVD Risk to Tamoxifen in Postmenopausal HR-positive Breast Cancer

AIs Have Similar CVD Risk to Tamoxifen in Postmenopausal HR-positive Breast Cancer

Women with breast cancer who were using aromatase inhibitors had no more increased risk for serious cardiovascular events than did women taking tamoxifen.

For Patients With Malignant Glioma, Optimism and Prognostic Awareness Not Mutually Exclusive

For Patients With Malignant Glioma, Optimism and Prognostic Awareness Not Mutually Exclusive

A study explored patient and caregiver awareness of disease curability and life expectancy with malignant glioma.

Feature Articles

Research Is Expanding Into the Use of Interleukin-12 as an Anticancer Agent

Research Is Expanding Into the Use of Interleukin-12 as an Anticancer Agent

Recent research has indicated the potential for IL-12 therapy to be effective in combination with new and emerging biologics including other immunomodulatory drugs.

Study Suggests Rising Incidence of Acute Kidney Injury Following RN and PN

Study Suggests Rising Incidence of Acute Kidney Injury Following RN and PN

Acute kidney injury incidence after radical nephrectomy and partial nephrectomy is increasing.

The Impact of Lifestyle on Colorectal Cancer

The Impact of Lifestyle on Colorectal Cancer

The link between lifestyle and colorectal cancer has been increasingly studied, highlighting the potential impact of the standard American diet and inactivity.

Updated 2016 NCCN Guidelines in Oncology for Multiple Myeloma Highlight Significant Changes in Clinical Practice

Updated 2016 NCCN Guidelines in Oncology for Multiple Myeloma Highlight Significant Changes in Clinical Practice

Several new regimen options for the treatment of as well as the recently FDA-approved combination drug regimens are among the changes made.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters